Corporate Board Profile
Tech Score: 0/100
Filing Date | Source Excerpt |
---|---|
2013-03-26 | He was a partner of Deloitte & Touche LLP with over 30 years of public accounting experience, including lead audit partner for high-tech companies. |
2014-03-19 | He was graduated from Fordham University (B.S.) and Long Island University (M.B.A.). He is a licensed Certified Public Accountant in New York. |
2015-04-22 | Mr. Shanley, age 67, has served as a member of our Board since March 2007. He has also served as our Lead Independent Director since May 2013. Since May 2012, he has served as a member of the Board of Directors of H&H Ventures Management, Inc., a wholly owned subsidiary of the Company. From February 2001 to December 31, 2006, he was a partner of Deloitte & Touche LLP. During his over 30 years of public accounting experience, he served as lead audit partner on numerous audit engagements for public and private companies and companies making public stock offerings. He served as lead audit partner primarily for biotechnology, pharmaceutical and high-tech companies, including companies enabled by nanotechnology. He has been actively involved on the Biotech Council of New Jersey, the New Jersey Technology Council, the New York Biotechnology Association, the Connecticut Venture Group, the Biotechnology Industry Organization and the NanoBusiness Alliance. He is Chairman of the board of directors of Redpoint Bio Corporation, a publicly held biotechnology company. He is an active member of the New York State Society of Certified Public Accountants and the American Institute of Certified Public Accountants. He is a licensed Certified Public Accountant in New York. He was graduated from Fordham University (B.S.) and Long Island University (M.B.A.). |
2016-04-20 | He was graduated from Fordham University (B.S.) and Long Island University (M.B.A.). We believe Mr. Shanley is qualified to serve on our Board because of his extensive prior financial, valuation and accounting experience, as well as his experience with companies investing in nanotechnology. |
2017-02-13 | Richard P. Shanley. He was a partner at Deloitte & Touche LLP with over 30 years of public accounting experience, including biotech and high-tech companies. |
2017-04-28 | He served as lead audit partner primarily for biotechnology, pharmaceutical and high-tech companies, including companies enabled by nanotechnology. He has been actively involved on the Biotech Council of New Jersey, the New Jersey Technology Council, the New York Biotechnology Association, the Connecticut Venture Group, the Biotechnology Industry Organization and the NanoBusiness Alliance. |
2018-04-30 | He graduated from Fordham University (B.S.) and Long Island University (M.B.A.). He is a licensed Certified Public Accountant in New York. |
2019-04-29 | He was a partner of Deloitte & Touche LLP with over 30 years of public accounting experience and served as lead audit partner primarily for biotechnology, pharmaceutical and high-tech companies. |
2020-03-25 | He was a partner of Deloitte & Touche LLP and served as lead audit partner primarily for biotechnology, pharmaceutical and high-tech companies. He graduated from Fordham University (B.S.) and Long Island University (M.B.A.). |
2021-03-02 | He is a licensed Certified Public Accountant in New York. He graduated from Fordham University (B.S.) and Long Island University (M.B.A.). |
2022-03-02 | He served as lead audit partner primarily for biotechnology, pharmaceutical and high-tech companies. He is a licensed Certified Public Accountant in New York. |
2023-03-23 | He graduated from Fordham University (B.S.) and Long Island University (M.B.A.). He is a licensed Certified Public Accountant in New York. |
2024-03-01 | He is a licensed Certified Public Accountant in New York. He graduated from Fordham University (B.S.) and Long Island University (M.B.A.). He served as lead audit partner primarily for biotechnology, pharmaceutical and high-tech companies. |
Data sourced from SEC filings. Last updated: 2025-10-12